CannaPharmaRX
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-7.65-2.61-7.17-1.48K-9.86-1.57-0.89-0.09-0.240.14-0.16-9.86
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-105.60-44.81-7.50-10.24-106.668.09-2.26-0.07-0.12-0.04-0.13-106.66
Price/Cash Flow ratio
-19.75-12.03-321.01N/A-32.44-10.35-35.38-0.40-1.45-0.23-1.18-32.44
Price/Free Cash Flow ratio
-18.53-12.02-321.01N/A-32.44-10.22-35.38-0.39-1.34-0.22-1.10-32.44
Price/Earnings Growth ratio
-0.00-0.020.0715.00-0.00-0.000.020.000.00-0.00-0.00-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-49.05%-0.02%-0.04%100.04%-69.16%-21.87%-11.53%-17.06%-31.56%N/AN/A-69.16%
Return on Assets
-221.38%-97378.98%-60062.98%-3.49%-30.64%-155.60%-253.60%-9043.89%-157.56%31.40%-225.57%-155.60%
Return On Equity
1380.29%1715.44%104.55%0.68%1080.79%-513.45%252.04%79.99%49.18%-30.34%85.95%85.95%
Return on Capital Employed
2774.89%1673.95%104.93%0.85%-23.07%-132.43%164.58%23.15%44.35%24.63%28.52%-23.07%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.00N/A
Quick Ratio
0.850.010.000.190.100.490.020.000.000.000.000.49
Cash ratio
0.820.000.190.190.070.000.010.000.000.000.000.00
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A-80.22-1.56-45.0084.826.31KN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A13.85KN/AN/AN/A2.55K10.18K79.51K8.56K31.14K127.20K127.20K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A11.850.100.910.571.1478.881.640.593.760.91
Debt Equity Ratio
N/AN/A-0.02-0.02-32.131.91-1.13-0.69-0.51-0.57-1.36-32.13
Long-term Debt to Capitalization
N/AN/AN/AN/A1.060.59N/AN/AN/AN/A-0.570.59
Total Debt to Capitalization
N/AN/A-0.02-0.021.030.658.33-2.30-1.06-1.36-19.690.65
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-1.24N/A
Cash Flow to Debt Ratio
N/AN/A-1.13N/A-0.10-0.40-0.05-0.26-0.16-0.32-0.12-0.12
Company Equity Multiplier
-6.23-0.01-0.00-0.19-35.273.29-0.99-0.00-0.31-0.96-0.36-35.27
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.061.001N/A11.0111.001.081.031.071
Cash Flow Coverage Ratio
N/AN/A-1.13N/A-0.10-0.40-0.05-0.26-0.16-0.32-0.12-0.12
Short Term Coverage Ratio
N/AN/A-1.13N/A-0.19-1.83-0.05-0.26-0.16-0.32-0.19-0.19
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A